or Try an Advanced Search...

    Targeted Therapy Stocks List

    Symbol Grade Name % Change
    ATRA D Atara Biotherapeutics, Inc. -0.66
    AVTX D Avalo Therapeutics, Inc. -11.47
    CELC F Celcuity Inc. -0.39
    IDYA F IDEAYA Biosciences, Inc. 4.15
    CRDF F Cardiff Oncology, Inc. -1.19
    CLRB F Cellectar Biosciences, Inc. 1.28
    BCAB F BioAtla, Inc. -6.08
    POAI F Predictive Oncology Inc. 5.58
    APTO F Aptose Biosciences, Inc. -10.66
    APLM F Apollomics Inc. -32.58
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Medical Instruments & Supplies
    Related Stock Lists: Clinical Medicine Medicine Cancer Oncology Biopharmaceutical Drugs Solid Tumors Acute Myeloid Leukemia Antineoplastic Drugs Biomarkers Biotechnology Chemotherapy Precision Medicine Advanced Solid Tumors Biology Cancer Immunotherapy Cancer Therapies Cell Biology Leukemia Non Small Cell Lung Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Targeted Therapy stocks.

    Symbol Grade Name Weight
    SBIO C ALPS Medical Breakthroughs ETF 1.87
    JFWD B Jacob Funds Inc. Jacob Forward ETF 1.74
    BBC F Virtus LifeSci Biotech Clinical Trials ETF 1.3
    CNCR F Loncar Cancer Immunotherapy ETF 1.07
    CANC D Tema Oncology ETF 0.9
    View all Targeted Therapy ETFs...
    Compare ETFs
    Compare JFWD to BBC Compare SBIO to CANC Compare SBIO to CNCR

        Targeted Therapy Stocks Recent News

        Date Stock Title
        Nov 21 APLM Apollomics’ Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split
        Nov 20 APTO Aptose Initiates TUSCANY Phase 1/2 Study for Newly Diagnosed AML Patients to Receive Tuspetinib-based Triplet Therapy
        Nov 19 CRDF Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS mutated mCRC
        Nov 19 CLRB Q3 2024 Cellectar Biosciences Inc Earnings Call
        Nov 18 CLRB Cellectar Biosciences, Inc. (CLRB) Q3 2024 Earnings Call Transcript
        Nov 18 CLRB Cellectar Biosciences GAAP EPS of -$0.40 misses by $0.03
        Nov 18 CLRB Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update
        Nov 18 IDYA IDEAYA Biosciences Appoints Stu Dorman as Chief Commercial Officer
        Nov 18 CLRB Earnings Scheduled For November 18, 2024
        Nov 15 CLRB Cellectar Biosciences Q3 2024 Earnings Preview
        Nov 15 IDYA Jim Cramer Says This Tobacco Stock Is 'Undervalued' But He's Not Recommending It
        Nov 15 ATRA Atara Biotherapeutics Third Quarter 2024 Earnings: Beats Expectations
        Related Industries: Biotechnology Diagnostics & Research Medical Instruments & Supplies
        Related Stock Lists: Clinical Medicine Medicine Cancer Oncology Biopharmaceutical Drugs Solid Tumors Acute Myeloid Leukemia Antineoplastic Drugs Biomarkers Biotechnology Chemotherapy Precision Medicine Advanced Solid Tumors Biology Cancer Immunotherapy Cancer Therapies Cell Biology Leukemia Non Small Cell Lung Cancer
        Targeted Therapy

        Targeted therapy is a type of cancer treatment that uses drugs or other substances to identify and attack specific cancer cells without harming normal cells. It works by targeting the molecules and pathways that are involved in the growth and spread of cancer cells. Targeted therapy is used to treat many types of cancer, including breast, lung, and colorectal cancer.

        Browse All Tags